The European Pharmacopoeia (Ph. Eur.) Commission held its 170th session on 22 and 23 June 2021. As the decision-making body of the Ph. Eur., the Commission adopted 69 texts that will be published in Ph. Eur. Supplement 10.8 and be effective as of 1 July 2022.
These 69 texts included the following 3 new monographs:
- Chinese motherwort (Leonuri herba) (2785)
- Purple coneflower herb expressed juice, stabilised with ethanol (2282)
- Purple coneflower expressed juice, stabilised without ethanol (2894).
The list of all adopted texts will be made available on the Ph. Eur. Work Programme web page in the coming weeks.
At this session, the Commission decided to suspend the monograph Gonadotrophin, equine serum, for veterinary use (0719) which means that the monograph will no longer be part of the Ph. Eur. as of Supplement 10.8, but will be kept on its work programme. More information on this will be published soon.
For more information, read the press release “Outcome of the 170th session of the European Pharmacopoeia Commission, June 2021”.